Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

This page's audience real numbers from our own analytics — open to see them
–Visitors
–Page views
–Clicks to vendors
–Time on page
–Reading now
Clicks to vendors, by tool
  • –
Top countries
  • –
Devices
  • –

– · counted by iTechGuides's own first-party analytics, bots removed, every figure rounded down · how we count

Benevolent Platform

#11 of 30 in AI Drug Discovery Software

Benevolent Platform: A broad discovery suite for teams connecting target research with compound and indication work. Ranked #11 of 30 in AI Drug Discovery Software by our editors (7.3/10); pricing: Pricing on request; best for teams prioritizing targets and repurposing compounds.

7.3/10Editor score
Benevolent Platform7.3 Contact BenevolentAI

At a glance

  • Editor score
    7.3 / 10
  • Pricing
    Pricing on request
  • Best for
    Teams prioritizing targets and repurposing compounds
  • Free plan
    No
  • Target identification
    Yes
  • Founded
    2013 · London, UK
  • Facts checked
    4 Oct 2026
  • Where it wins

    • Combines target identification, molecular design and repurposing workflows
    • Uses a multimodal biomedical knowledge graph to surface scientific evidence
    • Feeds experimental data back into the knowledge graph
  • Where it doesn't

    • Commercial access requires contacting sales
    • No free plan is offered
    • The breadth may not suit teams seeking a single-purpose tool

Our verdict on Benevolent Platform

Benevolent Platform is an AI-enabled drug discovery suite from BenevolentAI, intended for research teams working on complex diseases and biopharma organizations. It brings target identification and validation, molecular design, indication expansion, and drug repurposing into a shared workflow. That breadth suits teams deciding what biology to pursue while also exploring compounds or additional uses for existing drugs; it is less aligned with groups seeking only one focused research tool.

A central part of the approach is a multimodal biomedical knowledge graph that combines biomedical data with scientific expertise. The platform surfaces evidence to support target selection, and its workflows include hypotheses experimentally validated in human cell-based systems. Experimental data can feed back into the knowledge graph, linking discovery work with further analysis. This makes the suite relevant where teams want target evaluation, chemistry workflows, and indication exploration to inform one another, rather than operate as disconnected activities.

According to the vendor's published description, BenevolentAI uses the platform in its own discovery programs and in commercial collaborations with biopharma organizations. Commercial terms appear to be negotiated, and access is through contact with sales rather than a free plan. The listing is therefore a better fit for mid-market and enterprise research teams prepared to evaluate a commercial collaboration than for smaller groups looking for self-service access or transparent plan-based pricing. Teams whose main need is target prioritization alongside compound repurposing should consider it; those focused solely on a narrow task may prefer a more specialized option.

Your product? Our editors can test Benevolent Platform in depth and publish a review, labelled as paid · from $99/mo →

Benevolent Platform pricing

Plans Pricing on request No free plan — trial or paid only. Prices checked 4 Oct 2026.
See plans on benevolent.com

Benevolent Platform fact sheet

Free planNo
Paid fromNot verified
Target identificationYes
Molecule designYes
Drug repurposingYes
Discovery scopeSuite
Deployment optionsNot verified
Research publicationsYes
Built forMid-market, Enterprise (editorial estimate)
PricingPricing on request
Websitebenevolent.com
Facts checked4 Oct 2026

Alternatives to Benevolent Platform

See all Benevolent Platform alternatives →

Used Benevolent Platform? Be the first to review it

The editor score above is our own research. What this page doesn't have yet is a reader's view — what you used Benevolent Platform for, what worked and what didn't. No stars are seeded and no review is paid for; an editor reads every one before it appears.

Write a reviewTwo minutes · verified accounts only · read by an editor before it appears

Reviews come only from verified accounts. Sign in or create an account first — your e-mail is never shown.

Your rating

0 characters · at least 80, up to 3,000

Posted from your verified account. Reviews appear after an editor reads them, usually within two working days.

Featured on iTechGuides

Featured on iTechGuides — Benevolent Platform 7.3/10

Benevolent Platform is listed in our AI Drug Discovery Software directory. Add the badge to your site — it links back to this page.

<a href="https://www.itechguides.com/products/benevolent-platform/"><img src="https://www.itechguides.com/best/badge/benevolent-platform.svg" alt="Featured on iTechGuides" width="230" height="46"></a>

Reviewed by iTechGuides Editors · Editorial team · Updated Oct 2026

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. How we rank.

Last updated · How we research and update